Cadrenal Therapeutics Inc (CVKD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2024 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cadrenal Therapeutics Inc  (NASDAQ: CVKD)


Cadrenal Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cadrenal Therapeutics Inc's ROI in the second quarter of 2026?
Cadrenal Therapeutics Inc recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -366.83%.

Within the Healthcare sector 760 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 0 to 4324.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -34.09 % -19.17 % -32.84 % -25.87 % -11.28 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 4 3 3 4 7
Return On Investment (TTM) -366.83 % -330.14 % -303.59 % -277.54 % -214.45 %
CVKD's Overall Ranking # 4324 # 0 # 4082 # 3214 # 3528
Seq. Investment Change TTM -19.45 % -3.77 % -6.57 % -9 % -1.21 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -13 -14 -14 -13 -11

CVKD Company Profile >> Back to CVKD Roi Comparisons >> See Annual CVKD Return On Investment



Return On Investment CVKD's Ranking
Within: No.
Industry # 361
Sector # 761
Overall # 4324

Return On Investment Statistics
High Average Low
-93.68 %
-245.93 %
-366.83 %
(Jun 30 2024)   (Jun 30 2026)



  News about Cadrenal Therapeutics Inc Return on Investment ROI

Cadrenal Therapeutics Partners with Abbott to Advance Pivotal Study of Tecarfarin in LVAD Patients

March 4, 2025

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, has announced a significant advancement in its clinical pipeline. The company has entered into a collaboration agreement with Abbott (NYSE: ABT) to support its pivotal clinical trial, the TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial. This collaboration underscores the growing recognition of tecarfarin, an innovative oral Vitamin K antagonist (VKA), particularly in the management of anticoagulation for patients using Left Ventricular Assist Devices (LVADs).The TECH-LVAD study aims to evaluate the efficacy and safety of tecarfarin in patients with HeartMate 3 LVADs, a widely used device for advanced heart failure management. This partnership with Abbott leverages Abbott’s expertise in medical device technology and its extensive experience in patient care, creating a robust framework for the study and potentially accelerating the development process for this crucial therapeutic.





Financial Statements
Cadrenal Therapeutics Inc's II. Quarter Investments $ 4 Millions CVKD's Balance sheet
Cadrenal Therapeutics Inc's II. Quarter Income $ -3 Millions Quarterly CVKD's Income Statement
CVKD's Income by Division See CVKD's Income by Division


CVKD Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023
Total Investments in Millions 2 6 7 8 0
Y / Y Investment Growth -70.6 % -17.83 % -3.35 % - -
Net Income in Millions -2 -4 -11 -8 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -138.92 % -62.9 % -143.17 % -108.57 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CVKD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CVKD's Competitors
Subscribers only: Roi for Cadrenal Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CVKD's Customers

Other Ratios
CVKD's Roa CVKD's Inventory Turnover Ratio CVKD's Growth Rates CVKD's Dividend Statistics
CVKD's Profitability Ratios CVKD's Asset Turnover Ratio CVKD's Dividend Growth
CVKD's Roe CVKD's Valuation Ratios CVKD's Financial Strength Ratios CVKD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T11:41:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.